Navigation Links
QMed, Inc. Receives NASDAQ Delisting Letter
Date:4/18/2008

EATONTOWN, N.J., April 18 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today announced that it has received a NASDAQ staff determination letter dated April 14, 2008, notifying the Company that it has not complied with NASDAQ Marketplace Rule 4350(i)(1)(A) due to its failure to comply with the shareholder approval requirements in connection with a recent financing transaction. The letter stated that the terms of the transaction and completing the financing in violation of shareholder approval rules raises public interest concerns under Marketplace Rule 4300 and IM-4300 and serves as an additional basis for delisting. In addition, the letter indicated that the Company does not comply with the independent director and audit committee composition requirements, as set forth in Marketplace Rules 4350(c) (1) and 4350(d) (2), due to the recent resignation of a director, and is not eligible for a cure period to regain compliance, which serves as an additional basis for delisting.

Accordingly, unless the Company requests an appeal of this determination, trading of the Company's common stock will be suspended at the opening of business on April 23, 2008 and a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities from listing and registration on The NASDAQ Stock Market.

The Company was advised by NASDAQ that the Company may appeal Staff's determinations to the Panel, pursuant to the procedures set forth in the NASDAQ Marketplace Rule 4800 Series. A hearing request will stay the suspension of the Company's securities and the filing of the Form 25-NSE pending the Panel's decision, if received by April 21, 2008 prior to 4:00 pm. If the Company does not appeal S
'/>"/>

SOURCE QMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. QMed, Inc. Reports Year-End and Fourth Quarter Results
2. QMed, Inc. Announces $750,000 in Financing and Settlement with DAKOTACARE
3. QMed, Inc. Announces the Termination of Its New Jersey Special Needs Plan
4. QMed, Inc. Receives NASDAQ Letter
5. QMed, Inc. Retains Lazard Middle Market
6. QMed, Inc. Reports Third Quarter Results
7. QMed, Inc. Extends Agreement & Receives $550,000 Performance Bonus
8. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
9. Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
10. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
11. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... The medical waste management market is expected to reach USD ... 5.2%. The global medical waste management market is segmented based on type of waste, ... to register the highest growth rate in the medical waste management market, by service, ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding ... actress as the primary love interest in the film. The campaign is being called ... affects how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... food banks in commemorating “Hunger Action Month” during the entire month of September. ... Food Bank will be dedicating its efforts this September to an awareness campaign ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... companies, has completed a recapitalization with new investment partners Beecken Petty O’Keefe ... Group each offer extensive expertise and connections within the healthcare industry, which ...
Breaking Medicine News(10 mins):Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 2Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 3Health News:#IfOnlyYouKnew: Alameda County Community Food Bank Commemorates September as National Hunger Action Month 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4
... North America -, PRINCETON, N.J., Dec. 18 ... Barr has been named Covance,s Chief,Operating Officer, effective ... of Early Development North America, will assume operating,responsibility ... to,Joe Herring, Covance,s Chairman and Chief Executive Officer. ...
... slightly more effective than traditional lung scans, , , TUESDAY, ... a life-threatening blood clot in the lungs -- can ... a technique using CT scanning might be slightly more ... Canadian researchers found that computed tomographic pulmonary angiography (CTPA) ...
... team of researchers led by Mayo Clinic have designed a ... to destroy cancer cells that spread from primary tumors to ... addition, their study shows that this technology could be the ... , The study appeared in the Dec. 9 online issue ...
... screenings for those with severe illnesses, they may bring ... a recent study by Yale School of Medicine researchers ... study offers a new approach for assessing who is ... recommendations can be tailored more effectively to individual patients. ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... and hospitals throughout the United States,today announced that ... Healthcare,Conference, January 10, 2008, at 8:30 a.m. PST ... Paul Berger, Chairman and CEO, Tim Mayleben, President,and ...
... Dec. 18 Psoriasis Cure Now,a nonprofit patient ... an association between severe psoriasis and a significantly,increased ... psoriasis research. The,study, by a team of University ... severe psoriasis have a 50 percent,increased risk of ...
Cached Medicine News:Health News:Wendel Barr Appointed Chief Operating Officer of Covance 2Health News:Wendel Barr Appointed Chief Operating Officer of Covance 3Health News:CT Scans Catch More Clots in Lungs 2Health News:CT Scans Catch More Clots in Lungs 3Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Colon cancer screenings may not pay off and could pose harm to some 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008 2
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. This ... clinical specialty, aimed at improving patient care by ... adjust the dose of drugs for improving outcome. ...
(Date:9/2/2015)... -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced that ... Company,s Board of Directors has engaged Morgan Stanley  & ... to maximize shareholder value. Potential strategic ... process may include a possible sale of the Company, ...
(Date:9/2/2015)... WORCESTER, Mass. and ... -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: ... intention to implement a buccal cannabis co-development ... ) has been formalized. Generex ... Co-Development and Technology Licensing Agreement.  Pursuant to ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024 2Unilife Announces Review of Strategic Alternatives 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 2Generex Announces Formalization of Buccal Cannabis Co-Development Plan 3
... 2012  Bio-Pharmaceutical and medical device leaders are re-evaluating ... increasing regulatory and market pressures in the U.S., ... Best Practices, LLC. To identify which ... growth in the quickly changing healthcare industry, Best ...
... the premier providers of innovative supplies for continuous positive ... its fifth year with a variety of planned new ... high-quality standards and innovation that the home health care ... Circadiance has its sights set on being the ...
Cached Medicine Technology:Public Policy Staffing Study Offers Benchmark Opportunity for Bio-Pharma and Medical Device Companies 2Circadiance to Launch New Respiratory Supply Products 2
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
IBT Reference Laboratory is a national research and specialty clinical lab founded in 1983 that provides a wide range of tests and services in the area of allergy, clinical immunology and molecular b...
Marquette General Health System Reference Laboratory provides a full range of testing including, Chemistry, Hematology, Coagulation, Urinalysis, Microbiology, Cytology, Anatomic Pathology, Flow Cytom...
Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...
Medicine Products: